123 related articles for article (PubMed ID: 15071929)
21. M1-Like Macrophages Modulate Fibrosis and Inflammation of Orbital Fibroblasts in Graves' Orbitopathy: Potential Relevance to Soluble Interleukin-6 Receptor.
Lu Y; Wang Y; Wang Y; Wu Y; Huang Y; Liu X; Zhang S; Zhong S; Li Y; Li B; Sun J; Fang S; Zhou H
Thyroid; 2023 Mar; 33(3):338-350. PubMed ID: 36617890
[No Abstract] [Full Text] [Related]
22. Effects of interleukins on EGF-stimulated growth promotion in human thyroid cells: differential modifications by IL-2 and IL-6 in Graves' and normal thyroid cells.
Shimomura N; Itoh M; Okugawa T; Murata Y; Seo H
Endocr Regul; 1994 Jun; 28(2):55-65. PubMed ID: 7949016
[TBL] [Abstract][Full Text] [Related]
23. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
[TBL] [Abstract][Full Text] [Related]
24. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
Dik WA; Virakul S; van Steensel L
Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
[TBL] [Abstract][Full Text] [Related]
25. Slit2 Regulates Hyaluronan & Cytokine Synthesis in Fibrocytes: Potential Relevance to Thyroid-Associated Ophthalmopathy.
Fernando R; Smith TJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):e20-e33. PubMed ID: 32968816
[TBL] [Abstract][Full Text] [Related]
26. IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO.
Fang S; Huang Y; Wang S; Zhang Y; Luo X; Liu L; Zhong S; Liu X; Li D; Liang R; Miranda P; Gu P; Zhou H; Fan X; Li B
J Clin Endocrinol Metab; 2016 Aug; 101(8):2955-65. PubMed ID: 27224264
[TBL] [Abstract][Full Text] [Related]
27. Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy.
Rotondo Dottore G; Leo M; Casini G; Latrofa F; Cestari L; Sellari-Franceschini S; Nardi M; Vitti P; Marcocci C; Marinò M
Thyroid; 2017 Feb; 27(2):271-278. PubMed ID: 27824294
[TBL] [Abstract][Full Text] [Related]
28. Cell density-dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts.
Galgoczi E; Jeney F; Gazdag A; Erdei A; Katko M; Nagy DM; Ujhelyi B; Steiber Z; Gyory F; Berta E; Nagy EV
J Endocrinol; 2016 May; 229(2):187-96. PubMed ID: 26979769
[TBL] [Abstract][Full Text] [Related]
29. Astragaloside IV attenuates orbital inflammation in Graves' orbitopathy through suppression of autophagy.
Li H; Zhang Y; Min J; Gao L; Zhang R; Yang Y
Inflamm Res; 2018 Feb; 67(2):117-127. PubMed ID: 29127443
[TBL] [Abstract][Full Text] [Related]
30. Effect of Prunella vulgaris polysaccharides on cultured orbit fibroblasts in vitro from patients with thyroid-associated ophthalmopathy.
Li B; Guo J; Wang F; Cheng S; Zeng L
Exp Eye Res; 2020 Dec; 201():108276. PubMed ID: 32991886
[TBL] [Abstract][Full Text] [Related]
31. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.
Feldon SE; Park DJ; O'Loughlin CW; Nguyen VT; Landskroner-Eiger S; Chang D; Thatcher TH; Phipps RP
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3913-21. PubMed ID: 16249464
[TBL] [Abstract][Full Text] [Related]
32. Unique properties of orbital connective tissue underlie its involvement in Graves' disease.
Smith TJ
Minerva Endocrinol; 2003 Sep; 28(3):213-22. PubMed ID: 14605603
[TBL] [Abstract][Full Text] [Related]
33. PRL-1 overexpressed placenta-derived mesenchymal stem cells suppress adipogenesis in Graves' ophthalmopathy through SREBP2/HMGCR pathway.
Park M; Kim JY; Kang JM; Lee HJ; Banga JP; Kim GJ; Lew H
Stem Cell Res Ther; 2021 May; 12(1):304. PubMed ID: 34051850
[TBL] [Abstract][Full Text] [Related]
34. Orbital fibroblasts of Graves' orbitopathy stimulated with proinflammatory cytokines promote B cell survival by secreting BAFF.
Tang F; Chen X; Mao Y; Wan S; Ai S; Yang H; Liu G; Zou Y; Lin M; Dan L
Mol Cell Endocrinol; 2017 May; 446():1-11. PubMed ID: 28087387
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts; A Potential Pleiotropic Effect in Graves' Orbitopathy.
Galgoczi E; Katko M; Papp FR; Csiki R; Csiha S; Erdei A; Bodor M; Ujhelyi B; Steiber Z; Gyory F; Nagy EV
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615214
[TBL] [Abstract][Full Text] [Related]
36. CD40 ligand induces expression of vascular cell adhesion molecule 1 and E-selectin in orbital fibroblasts from patients with Graves' orbitopathy.
Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):573-82. PubMed ID: 25576172
[TBL] [Abstract][Full Text] [Related]
37. The protective effect of antioxidants on orbital fibroblasts from patients with Graves' ophthalmopathy in response to oxidative stress.
Tsai CC; Wu SB; Kao SC; Kau HC; Lee FL; Wei YH
Mol Vis; 2013; 19():927-34. PubMed ID: 23687429
[TBL] [Abstract][Full Text] [Related]
38. Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves' ophthalmopathy.
Kim JY; Park S; Lee HJ; Lew H; Kim GJ
Stem Cell Res Ther; 2020 Nov; 11(1):469. PubMed ID: 33153489
[TBL] [Abstract][Full Text] [Related]
39. Novel aspects of orbital fibroblast pathology.
Smith TJ
J Endocrinol Invest; 2004 Mar; 27(3):246-53. PubMed ID: 15165000
[TBL] [Abstract][Full Text] [Related]
40. Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists.
Heufelder AE; Bahn RS
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):120-7. PubMed ID: 8300338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
